By
Michael Grunwald
Published: July 4, 2015, 11:17 a.m.·
Tags:
Access,
Pharma industry
A recent draft of the Trans-Pacific Partnership free-trade deal would give U.S. pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in U.S. law.
Read More →